Literature DB >> 7175841

Assessment methods of disease activity in juvenile rheumatoid arthritis--evaluated in a prednisolone/placebo double-blind study.

T K Kvien, H M Høyeraal, B Sandstad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7175841

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Validity of reported pain as a measure of clinical state in juvenile rheumatoid arthritis.

Authors:  C K Ross; J V Lavigne; J R Hayford; A R Dyer; L M Pachman
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

2.  Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.

Authors:  T K Kvien; H M Høyeraal; B Sandstad; E Kåss
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

3.  Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor.

Authors:  K B Eberhardt; L Truedsson; H Pettersson; B Svensson; L Stigsson; J L Eberhardt; F A Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

4.  Early rheumatoid arthritis--onset, course, and outcome over 2 years.

Authors:  K B Eberhardt; L C Rydgren; H Pettersson; F A Wollheim
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis.

Authors:  P C Gøtzsche; H K Johansen
Journal:  BMJ       Date:  1998-03-14

6.  Bone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficits.

Authors:  Jon M Burnham; Justine Shults; Sarah E Dubner; Harjeet Sembhi; Babette S Zemel; Mary B Leonard
Journal:  Arthritis Rheum       Date:  2008-08

Review 7.  Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.

Authors:  P C Gotzsche; H K Johansen
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 8.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

9.  Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.

Authors:  K Müller; F K Pedersen; A Wiik; K Bendtzen
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

10.  Reducing fatigue in pediatric rheumatic conditions: a systematic review.

Authors:  K Kant-Smits; M Van Brussel; S Nijhof; J Van der Net
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-08       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.